If the COVID vaccine pill generated antibodies in pigs, does it mean it has great potential?
Oramed CEO Nadav Kidron, who calls the prospective vaccine, Oravax, explained that where the shots only target one SARS-CoV-2 surface protein, his pill targets three.
Furthermore, the proteins it targets are not prone to mutation; hence it will “keep the vaccine effective in the face of new variants.”
Israel Is Already One Step Ahead
Israel already has the means to develop a COVID vaccine pill because they’re a step ahead when it comes to vaccination efforts. In fact, they are the first country in the world to fully vaccinate the majority of its citizens.
Now, they are also planning to give booster shots to their fully vaccinated immunocompromised citizens.
However, there’s still a growing suggestion that should we need booster shots, they need not be the same formulation as the initial jabs. Additionally, some experts believe that mixing and matching different vaccine brands would be beneficial.
Comments
Share your thoughts
Be the first to let Hello Doctor know your thoughts!
Join Us or Log In to join the discussion